A model-based approach for simulating adaptive clinical studies with surrogate endpoints used for interim decision-making

por Chen, Xiaotian, Hartford, Alan, Zhao, Jun
Publicado no Contemp Clin Trials Commun (2020)

Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast

por Knorr, Barbara, Hartford, Alan, Li, Xiujiang (Susie), Yang, Amy Yifan, Noonan, Gertrude, Migoya, Elizabeth
Publicado em 2010

Clinical Electron Paramagnetic Resonance (EPR) Oximetry using India Ink

por Williams, Benjamin B., Khan, Nadeem, Zaki, Bassem, Hartford, Alan, Ernstoff, Marc S., Swartz, Harold M.
Publicado em 2010

Stability of serrated gold coil markers in prostate localization

por Gates, Larry L., Gladstone, David J., Kasibhatla, Mohit S., Marshall, John F., Seigne, John D., Hug, Eugen, Hartford, Alan C.
Publicado no J Appl Clin Med Phys (2011)

Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist

por Li, Xiujiang (Susie), Nielsen, Jace, Cirincione, Brenda, Li, Hankun, Addy, Carol, Wagner, John, Hartford, Alan, Erondu, Ngozi, Gantz, Ira, Morgan, Jerry, Stone, Julie
Publicado em 2010

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS)

por Seung, Steven K., Larson, David A., Galvin, James M., Mehta, Minesh P., Potters, Louis, Schultz, Christopher J., Yajnik, Santosh V., Hartford, Alan C., Rosenthal, Seth A.
Publicado no Am J Clin Oncol (2013)

Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

por Lieberman, Frank S, Wang, Meihua, Robins, H Ian, Tsien, Christina I, Curran, Walter J, Werner-Wasik, Maria, Smith, Ryan P, Schultz, Christopher, Hartford, Alan C, Zhang, Peixin, Mehta, Minesh P
Publicado no Int J Radiat Oncol Biol Phys (2018)

Clinical EPR: Unique Opportunities and Some Challenges

por Swartz, Harold M., Williams, Benjamin B., Zaki, Bassem I., Hartford, Alan C., Jarvis, Lesley A., Chen, Eunice, Comi, Richard J., Ernstoff, Marc S., Hou, Huagang, Khan, Nadeem, Swarts, Steven G., Flood, Ann B., Kuppusamy, Periannan
Publicado em 2014

ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402

por Lassman, Andrew, Won, Minhee, Gregory Cairncross, J, Shaw, Edward, Ashby, Lynn, Souhami, Luis, Laack, Nadia, Fink, Karen, Macdonald, David, Bahary, Jean-Paul, Hartford, Alan, Whitton, Anthony, Werner-Wasik, Maria, Laperriere, Normand, Suh, John, Robinson, Clifford, Mehta, Minesh
Publicado no Neuro Oncol (2019)

Experimentally Observed Cherenkov Light Generation in the Eye During Radiotherapy

por Tendler, Irwin I., Hartford, Alan, Jermyn, Michael, LaRochelle, Ethan, Cao, Xu, Borza, Victor, Alexander, Daniel, Bruza, Petr, Hoopes, Jack, Moodie, Karen, Marr, Brian P., Williams, Benjamin B., Pogue, Brian W., Gladstone, David J., Jarvis, Lesley A.
Publicado no Int J Radiat Oncol Biol Phys (2019)

Genetic landscape of extreme responders with anaplastic oligodendroglioma

por Holdhoff, Matthias, Cairncross, Gregory J., Kollmeyer, Thomas M., Zhang, Ming, Zhang, Peixin, Mehta, Minesh P., Werner-Wasik, Maria, Souhami, Luis, Bahary, Jean-Paul, Kwok, Young, Hartford, Alan C., Chakravarti, Arnab, Yegnasubramanian, Srinivasan, Vogelstein, Bert, Papadopoulos, Nickolas, Kinzler, Kenneth, Jenkins, Robert B., Bettegowda, Chetan
Publicado no Oncotarget (2017)

Gleason Pattern 5 Is Associated with an Increased Risk for Metastasis Following Androgen Deprivation Therapy and Radiation: An Analysis of RTOG 9202 and 9902.

por Hamstra, Daniel A, Pugh, Stephanie L, Lepor, Herbert, Rosenthal, Seth A, Pienta, Kenneth J, Gomella, Leonard, Peters, Christopher, Paul D’Souza, David, Zeitzer, Kenneth L, Jones, Christopher U, Hall, William A., Horwitz, Eric, Pisansky, Thomas M, Souhami, Luis, Hartford, Alan C, Dominello, Michael, Feng, Felix, Sandler, Howard M
Publicado no Radiother Oncol (2019)

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

por McCormick, Beryl, Winter, Kathryn, Hudis, Clifford, Kuerer, Henry Mark, Rakovitch, Eileen, Smith, Barbara L., Sneige, Nour, Moughan, Jennifer, Shah, Amit, Germain, Isabelle, Hartford, Alan C., Rashtian, Afshin, Walker, Eleanor M., Yuen, Albert, Strom, Eric A., Wilcox, Jeannette L., Vallow, Laura A., Small, William, Pu, Anthony T., Kerlin, Kevin, White, Julia
Publicado no J Clin Oncol (2015)

NRG Oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU vs standard RT and BCNU for malignant glioma patients

por Ali, Arif N., Zhang, Peixin, Alfred Yung, W.K., Chen, Yuhchyau, Movsas, Benjamin, Urtasun, Raul C., Jones, Christopher U., Choi, Kwang N., Michalski, Jeff M., Fischbach, A. Jennifer, Markoe, Arnold M., Schultz, Christopher J., Penas-Prado, Marta, Garg, Madhur K., Hartford, Alan C., Kim, Harold E., Won, Minhee, Curran, Walter J.
Publicado no J Neurooncol (2018)

A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radi...

por Rosenthal, Seth A., Hunt, Daniel, Sartor, A. Oliver, Pienta, Kenneth J., Gomella, Leonard, Grignon, David, Rajan, Raghu, Kerlin, Kevin J., Jones, Christopher U., Dobelbower, Michael, Shipley, William U., Zeitzer, Kenneth, Hamstra, Daniel A., Donavanik, Viroon, Rotman, Marvin, Hartford, Alan C., Michalski, Jeffrey, Seider, Michael, Kim, Harold, Kuban, Deborah A., Moughan, Jennifer, Sandler, Howard
Publicado no Int J Radiat Oncol Biol Phys (2015)

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

por Willett, Christopher G, Boucher, Yves, di Tomaso, Emmanuelle, Duda, Dan G, Munn, Lance L, Tong, Ricky T, Chung, Daniel C, Sahani, Dushyant V, Kalva, Sanjeeva P, Kozin, Sergey V, Mino, Mari, Cohen, Kenneth S, Scadden, David T, Hartford, Alan C, Fischman, Alan J, Clark, Jeffrey W, Ryan, David P, Zhu, Andrew X, Blaszkowsky, Lawrence S, Chen, Helen X, Shellito, Paul C, Lauwers, Gregory Y, Jain, Rakesh K
Publicado em 2004

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

por Roach, Mack, Moughan, Jennifer, Lawton, Colleen A F, Dicker, Adam P, Zeitzer, Kenneth L, Gore, Elizabeth M, Kwok, Young, Seider, Michael J, Hsu, I-Chow, Hartford, Alan C, Horwitz, Eric M, Yamoah, Kosj, Jones, Christopher U, Michalski, Jeff M, Lee, W Robert, Pisansky, Thomas M, Rabinovitch, Rachel, Rotman, Marvin, Pryzant, Rodger M, Kim, Harold E, Thomas, Charles R, Shipley, William U, Sandler, Howard M
Publicado no Lancet Oncol (2018)